<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200305046700N15</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-23</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Kaplan Tenodesis on ACL Reconstruction Outcomes</public_title>
      <acronym></acronym>
      <scientific_title>Comparative study of treatment outcome in patients with anterior cruciate ligament injury undergoing reconstruction surgery with or without distal Kaplan tenodesis: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/84889</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be performed using random permuted blocks with fixed size of 4. The sequence will be generated by a random number generator in Excel and placed in numbered, sealed, opaque envelopes. At the time of surgery, the next envelope will be opened by an individual independent of the surgical team, and the patient will be allocated to one of two groups (distal Kaplan tenodesis or no tenodesis) based on the code inside. Allocation concealment is ensured as those involved in recruitment, surgery, and assessment are unaware of the sequence, Blinding description: In this study, patients, the clinical evaluator, and the data analyst are blinded to the type of procedure (with or without distal Kaplan tenodesis). Only the surgeon is aware of the procedure due to the nature of the intervention. Patients are not informed before surgery and observe no difference in dressings or wound appearance post-operatively. The clinical evaluator has no access to surgical records during 3- and 9-month follow-ups, and patients are instructed not to disclose their procedure type. The data analyst remains blinded until completion of statistical analyses.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Anterior Cruciate Ligament Injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Group undergoing Kaplan Tendonectomy after ACL reconstruction. For distal Kaplan tenodesis surgery, a 10-centimeter incision is made on the distal and lateral aspect of the thigh, at the mid-portion of the iliotibial band (ITB), with a slight inclination toward Gerdy’s tubercle. Then, a 10 × 1 centimeter strip of the ITB is incised. The proximal portion is detached, while the distal portion remains attached to the tibia at Gerdy’s tubercle.After preparing the graft, an appropriate reamer is used to create a tunnel in the femur. Finally, the graft is passed over the lateral collateral ligament (LCL), preserving the superior lateral genicular artery, and tenodesis of the graft is performed at 90 degrees of knee flexion and in a neutral rotation position. Intervention 2: Control group: Group undergoing ACL reconstruction only (Without Kaplan Tenodesis).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No decision yet</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Razzaghof</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.17, Sheybani Alley, North Jamalzadeh Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733141</zip>
        <telephone>+98 21 6658 0196</telephone>
        <email>m.razzaghof@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Razzaghof</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.17, Sheybani Alley, North Jamalzadeh Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1419733141</zip>
        <telephone>+98 21 6658 0196</telephone>
        <email>m-razzaghof@razi.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adult patients aged 18 to 55 years
Anterior Cruciate Ligament (ACL) injuries that are eligible for surgery</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Anterior Cruciate Ligament (ACL) revision surgery
need for bilateral ACL reconstruction surgery
patients requiring simultaneous repair or reconstruction of the posterior cruciate ligament and medial or lateral collateral ligament,
patients with symptomatic articular cartilage defects requiring surgery beyond debridement, and an unhealthy lateral meniscus
patients requiring simultaneous osteotomy
patients whose contralateral knee is positive for any of the tests including the Anterior Drower test, Posterior Drower test, Lachman test, Pivot shift test, and rotational stability tests that raise suspicion of ligament damage</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S83.51</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sprain of anterior cruciate ligament of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Group undergoing Kaplan Tendonectomy after ACL reconstruction. For distal Kaplan tenodesis surgery, a 10-centimeter incision is made on the distal and lateral aspect of the thigh, at the mid-portion of the iliotibial band (ITB), with a slight inclination toward Gerdy’s tubercle. Then, a 10 × 1 centimeter strip of the ITB is incised. The proximal portion is detached, while the distal portion remains attached to the tibia at Gerdy’s tubercle.After preparing the graft, an appropriate reamer is used to create a tunnel in the femur. Finally, the graft is passed over the lateral collateral ligament (LCL), preserving the superior lateral genicular artery, and tenodesis of the graft is performed at 90 degrees of knee flexion and in a neutral rotation position.</i_keyword>
      <i_keyword>Control group: Group undergoing ACL reconstruction only (Without Kaplan Tenodesis)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The amount of anterior tibial displacement. Timepoint: 3 months and 9 months after surgery. Method of measurement: Lachman test.</prim_outcome>
      <prim_outcome>Rotational stability of the knee joint. Timepoint: 3 months and 9 months after surgery. Method of measurement: pivot shift test.</prim_outcome>
      <prim_outcome>The lysholm questionnaire score. Timepoint: 3 months and 9 months after surgery. Method of measurement: Lysholm knee questionnaire.</prim_outcome>
      <prim_outcome>IKDC (International Knee Documentation Committee) score. Timepoint: 3 months and 9 months after surgery. Method of measurement: International Knee Documentation Committee (IKDC) Questionnaire.</prim_outcome>
      <prim_outcome>Tegner Activity Scale (TAS) score. Timepoint: 3 months and 9 months after surgery. Method of measurement: Tanger Activity Score Questionnaire.</prim_outcome>
      <prim_outcome>VAS (Visual Analogue Scale) score. Timepoint: 3 months and 9 months after surgery. Method of measurement: Visual Analog Scale (VAS) questionnaire.</prim_outcome>
      <prim_outcome>The exact amount of anterior tibial displacement based on the KT-1000 test grade. Timepoint: 3 months and 9 months after surgery. Method of measurement: KT1000 Arthrometer.</prim_outcome>
      <prim_outcome>The need for reoperation. Timepoint: 3 months and 9 months after surgery. Method of measurement: Surgeon Evaluation and Examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-20</approval_date>
        <contact_name>Ethics committee of Imam Khomeini Hospital Complex/ Tehran University of Medical Sciences</contact_name>
        <contact_address>Imam Khomeini Hospital Complex, East Baqerkhan Street, North Chamran Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
